Honeywell International’s ResMed RMD Stock Holding History

Honeywell International’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-403,300	Closed	-$20.4M	–	196
2014 Q2	$20.4M	Sell	403,300 -240,000	-37%	-$11.9M	0.47%	88
2014 Q1	$28.7M	Buy	643,300 +97,200	+18%	+$4.37M	0.69%	53
2013 Q4	$25.7M	Buy	+546,100	New	+$27.6M	0.62%	66

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Honeywell International's RMD Position: Q3 2014 in Review

Honeywell International sold out of ResMed (RMD) in Q3 2014, closing a stake of 403,300 shares — an estimated $20.4M sold.

Honeywell International first reported a position in RMD in Q4 2013 and held it in 3 quarters. The position peaked at $28.7M in Q1 2014. 300 funds tracked by Wall St. Rank hold RMD as of Q3 2014.

Honeywell International reported no remaining ResMed position as of Q3 2014 after selling out during the quarter.
Honeywell International sold 403,300 ResMed shares in Q3 2014, an estimated $20.4M.
Honeywell International first reported a position in ResMed in Q4 2013 and held it in 3 quarters.
Honeywell International's ResMed position peaked at $28.7M in Q1 2014.
300 funds tracked by Wall St. Rank held ResMed as of Q3 2014.

Based on Honeywell International's 13F filing for Q3 2014, filed 30 Oct 2014.